XSHE
300165
Market cap369mUSD
Jul 10, Last price
5.09CNY
1D
0.59%
1Q
-3.96%
Jan 2017
-49.10%
IPO
-42.77%
Name
Jiangsu Skyray Instrument Co Ltd
Chart & Performance
P/E
—
P/S
4.07
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.07%
Rev. gr., 5y
-16.69%
Revenues
619m
-27.26%
Net income
-233m
L+139.25%
CFO
204m
+83.46%
Dividend
Jun 24, 20210.009 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Skyray Instrument Co., Ltd. provides instruments in spectroscopy and chromatography fields. It also offers spectrometer comprising gold, alloy, mineral, soil, oil, and food analyzer; RoHS tester, and coating thickness measurement instruments. In addition, the company provides atomic absorption spectrometer, mass spectrometry, chromatograph, metal analyzer, carbon and sulfur analyzer, sample preparation system, optical metrology, and skyray instruments. Further, it offers COVID-19 test kits. The company serves electronics, electric appliances, jewelries, toys, food, construction material, metallurgy, minerals, plastic, petroleum, oil, chemistry, medicine, and other sectors. Jiangsu Skyray Instrument Co., Ltd. was founded in 2006 and is based in Kunshan, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||